Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 806 results for "hodgkin"

Takeda announces availability of Hodgkin lymphoma or ALCL drug

Takeda Pharmaceutical Company Limited has announced the availability of ADCETRIS 50mg for intravenous drip infusion, indicated for the treatment for patients with CD30 positive relapsed or refractory Hodgkin lymphoma, or HL, or relapsed or ..., 1 day ago

204 images for hodgkin

KPHO Phoenix, 3 days ago
Dominion Post, 3 days ago
American Journal of Hematology, 1 week ago, 1 week ago
Pocono Record, 2 days ago
British Journal of Haematology, 1 week ago
CNN, 1 week ago
Cleveland Banner, 1 week ago
I Stock Analyst, 4 days ago
The Palm Beach Post, 5 days ago


_ Advantage Chevrolet, Hodgkins/Countryside, will be awarding a 2015 Chevrolet Tahoe to the winner of the Chevrolet/GM Military Discount sponsored 'America is Strong' sweepstakes at the dealership located at 9510 W. Joliet Rd, Hodgkins, IL, 60525, ...
 Chicago Tribune3 days ago

USDM Life Sciences Hires Leader in Serialization and Enterprise Systems, Grant Hodgkins as Vice President of Commercial Practice

SANTA BARBARA, CA--(Marketwired - Apr 15, 2014) - USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, hires Grant Hodgkins as Vice President of the Commercial Practice. In his new role, Hodgkins will ...
 Reuters4 days ago USDM LIFE SCIENCES : Hires Leader in Serialization and Enterprise Systems, Grant Hodgkins as Vice President of Commercial Practice  4 Traders4 days ago

Northern Football League senior results | April 12

NORTHERN FOOTBALL LEAGUE DIVISION 1 HEIDELBERG 2.5 WHITTLESEA 2.1 Goals: Heidelberg: J Hodgkin 5 A Young 2 C Sargeant J Allery C Gaylard M Finn. Whittlesea: M Scholard 3 L Hobbs 2 J Dyson A Fairchild J Daniel J Page M Dyson R Dyson. Best: ...
 Melbourne Times Weekly6 days ago

Bendamustine plus rituximab noninferior to standard therapy in NHL, mantle cell lymphomas

In patients with slowly progressing non-Hodgkin's lymphoma or mantle cell lymphoma, a regimen of bendamustine and rituximab is noninferior to standard treatment in terms of response rate and safety profile, according to findings from the BRIGHT ...
 Orthopedics Today1 week ago Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma  Journal of Clinical Oncology2 weeks ago Mantle Cell Lymphoma -- Still More Questions Than Answers  American Journal of Public Health2 weeks ago Lymphoma Research Foundation Convenes Scientific Meeting of World Leading Mantle Cell Lymphoma Experts  Digital Journal2 days ago
Med India

Hormone Therapy Linked to Lower Non-Hodgkin Lymphoma Risk

How will we, as individuals, and a society, live with brains at risk for Alzheimer's disease dementia? As part of Health Affairs' April issue, a theme issue focusing on Alzheimer's, a neurodegenerative disease ethicist and clinician with the ...
 Infrosoft1 week ago Menopausal hormone therapy may lower risk of B-cell non-Hodgkin lymphoma  News-Medical.Net1 week ago Non-Hodgkin Lymphoma Gets Easier to Treat With a New Drug  Med India2 months ago Low CD4 count during HIV therapy increases risk of virus-related non-AIDS cancers  Aidsmap1 week ago

Changes in Arctic peat chemistry boost CH4 release [Environmental Sciences]

Suzanne B. Hodgkins a , 1 , Malak M. Tfaily a , Carmody K. McCalley b , Tyler A. Logan c , Patrick M. Crill d , Scott R. Saleska b , Virginia I. Rich e , and Jeffrey P. Chanton a , 1 a Department of Earth, Ocean, and Atmospheric Science, ...
 PNAS1 week ago
Pharmaceutical Technology

Halozyme Announces Roche Marketing Authorization For MabThera SC For Patients With Common Forms Of Non-Hodgkin Lymphoma In European Union

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced that the European Commission (EC) has approved Roche's new subcutaneous (SC) formulation of MabThera(®)( )(rituximab) ...
 NewsRX2 weeks ago Roche receives EC approval for non-Hodgkin Lymphoma drug  Individual.com2 weeks ago Halozyme: European Approval Of Roche's MabThera SC For Non-Hodgkin Lymphoma  RTTNews.com3 weeks ago EC approves Roche's SC formulation of MabThera for common forms of non-Hodgkin lymphoma  News-Medical.Net3 weeks ago

Brittany Daniel Reveals Post-Cancer Depression

12:30pm Actress Brittany Daniel spent the past three years waging a private battle against stage IV non-Hodgkin's lymphoma, but The Game star says it was after she received a clean bill of health that she fell into a depression. I think some ...
 ABC News2 weeks ago Brittany Daniel talks cancer, being only white woman on The Game  RollingOut1 week ago

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

Summary GlobalData's clinical trial report, B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 provides data on the B-Cell Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating ...
 MarketResearch.com1 week ago Research and Markets: Global B-Cell Non-Hodgkin Lymphoma Clinical Trials Review  TMC Net1 week ago Global B-Cell Non-Hodgkin Lymphoma Clinical Trials Review  Individual.com1 week ago RESEARCH AND MARKETS : Global B-Cell Non-Hodgkin Lymphoma Clinical Trials Review  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less